Update on role of direct renin inhibitor in diabetic kidney disease (Q38200133)

30 August 2017

Update on role of direct renin inhibitor in diabetic kidney disease (English)

1 reference

30 August 2017

Pradeep Dhakarwal

1

1 reference

30 August 2017

Vibha Agrawal

2

1 reference

30 August 2017

Anshul Kumar

3

1 reference

30 August 2017

Kiran M Goli

4

1 reference

30 August 2017

Varun Agrawal

5

1 reference

30 August 2017

31 March 2014

1 reference

30 August 2017

1 reference

30 August 2017

36

1 reference

30 August 2017

6

1 reference

30 August 2017

963-969

1 reference

US Renal Data System 2012 Annual Data Report

30 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Renin, prorenin and the putative (pro)renin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Immunocytochemical localization of prorenin, renin, and cathepsins B, H, and L in juxtaglomerular cells of rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Cathepsin B is not the processing enzyme for mouse prorenin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Tissue angiotensin-converting-enzyme (ACE) deficiency leads to a reduction in oxidative stress and in atherosclerosis: studies in ACE-knockout mice type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

(Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Renin, (pro)renin and receptor: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

The (pro)renin receptor/ATP6AP2 is essential for vacuolar H+-ATPase assembly in murine cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

The intrarenal renin-angiotensin system and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Activation of a local tissue angiotensin system in podocytes by mechanical strain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Major role for ACE-independent intrarenal ANG II formation in type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

The role of direct renin inhibition in clinical practice: focus on combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Aldosterone 'escape' vs 'breakthrough'.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Structure-based design of aliskiren, a novel orally effective renin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Aliskiren enhances protective effects of valsartan against type 2 diabetic nephropathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Aliskiren combined with losartan in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Aliskiren as an alternative in a patient with life-threatening ACE inhibitor-induced angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

Determinants of Progression from Microalbuminuria to Proteinuria in Patients Who Have Type 1 Diabetes and Are Treated with Angiotensin-Converting Enzyme Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2014.900425

10.3109/0886022X.2014.900425

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference